dafna yahav
Quick facts
Marketed products
- The Pfizer mRNA-based BNT162b2 vaccine · Immunology / Infectious Disease
BNT162b2 is an mRNA vaccine that instructs cells to produce the SARS-CoV-2 spike protein, triggering an immune response to prevent COVID-19 infection.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: